Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Device Removal | 15 | 2023 | 636 | 4.130 |
Why?
|
| Defibrillators, Implantable | 19 | 2023 | 1499 | 3.350 |
Why?
|
| Electrodes, Implanted | 10 | 2020 | 833 | 2.610 |
Why?
|
| Equipment Failure | 9 | 2015 | 577 | 1.180 |
Why?
|
| Arrhythmias, Cardiac | 7 | 2022 | 2255 | 0.940 |
Why?
|
| Pacemaker, Artificial | 5 | 2015 | 815 | 0.660 |
Why?
|
| Vena Cava, Superior | 2 | 2020 | 197 | 0.570 |
Why?
|
| Prosthesis-Related Infections | 2 | 2012 | 487 | 0.490 |
Why?
|
| Electric Injuries | 1 | 2013 | 25 | 0.450 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 1 | 2014 | 122 | 0.440 |
Why?
|
| Heart-Assist Devices | 1 | 2023 | 1291 | 0.420 |
Why?
|
| Pericardial Effusion | 1 | 2014 | 247 | 0.400 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2013 | 162 | 0.390 |
Why?
|
| Silicones | 1 | 2012 | 227 | 0.390 |
Why?
|
| Coronary Sinus | 1 | 2012 | 84 | 0.380 |
Why?
|
| Electric Countershock | 2 | 2010 | 537 | 0.360 |
Why?
|
| Cardiac Pacing, Artificial | 2 | 2010 | 866 | 0.330 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2015 | 553 | 0.330 |
Why?
|
| Iatrogenic Disease | 1 | 2012 | 538 | 0.320 |
Why?
|
| Cefazolin | 1 | 2009 | 94 | 0.310 |
Why?
|
| Heart Failure | 3 | 2023 | 11847 | 0.300 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2012 | 919 | 0.290 |
Why?
|
| Postoperative Complications | 3 | 2015 | 15697 | 0.280 |
Why?
|
| Hydrazones | 1 | 2005 | 102 | 0.250 |
Why?
|
| Myocarditis | 1 | 2012 | 766 | 0.240 |
Why?
|
| Myocardial Ischemia | 1 | 2015 | 2164 | 0.230 |
Why?
|
| Pyridazines | 1 | 2005 | 200 | 0.220 |
Why?
|
| Bacterial Infections | 1 | 2012 | 1403 | 0.220 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2009 | 643 | 0.220 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2012 | 1572 | 0.220 |
Why?
|
| Cardiology | 1 | 2014 | 1723 | 0.220 |
Why?
|
| Cardiotonic Agents | 1 | 2005 | 546 | 0.200 |
Why?
|
| Equipment Design | 5 | 2015 | 3520 | 0.200 |
Why?
|
| Cardiomegaly | 1 | 2004 | 593 | 0.190 |
Why?
|
| Electrocardiography | 2 | 2015 | 6414 | 0.180 |
Why?
|
| Treatment Outcome | 14 | 2020 | 65017 | 0.180 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2020 | 57 | 0.180 |
Why?
|
| Databases, Factual | 1 | 2015 | 8035 | 0.170 |
Why?
|
| Surgical Wound Infection | 1 | 2009 | 1527 | 0.170 |
Why?
|
| Clinical Competence | 1 | 2014 | 4783 | 0.160 |
Why?
|
| Veterans | 1 | 2012 | 2642 | 0.160 |
Why?
|
| Angioplasty, Balloon | 1 | 2020 | 597 | 0.140 |
Why?
|
| Myocytes, Cardiac | 1 | 2005 | 1657 | 0.140 |
Why?
|
| Tachycardia, Ventricular | 2 | 2015 | 1303 | 0.130 |
Why?
|
| Oxidative Stress | 3 | 2005 | 3106 | 0.130 |
Why?
|
| Coronary Artery Disease | 1 | 2015 | 6659 | 0.120 |
Why?
|
| Phrenic Nerve | 1 | 2015 | 79 | 0.120 |
Why?
|
| Tachycardia, Ectopic Atrial | 1 | 2015 | 65 | 0.120 |
Why?
|
| Ventricular Remodeling | 1 | 2002 | 1261 | 0.120 |
Why?
|
| Feasibility Studies | 3 | 2018 | 5201 | 0.110 |
Why?
|
| Humans | 29 | 2023 | 760621 | 0.110 |
Why?
|
| Blood Vessels | 1 | 1999 | 1112 | 0.110 |
Why?
|
| Electromagnetic Fields | 1 | 2015 | 296 | 0.110 |
Why?
|
| Male | 17 | 2020 | 359744 | 0.110 |
Why?
|
| Female | 17 | 2020 | 391270 | 0.100 |
Why?
|
| Retrospective Studies | 9 | 2020 | 80372 | 0.100 |
Why?
|
| Thromboembolism | 1 | 2018 | 1017 | 0.100 |
Why?
|
| Catheter Ablation | 2 | 2015 | 2758 | 0.100 |
Why?
|
| Forecasting | 1 | 2020 | 2932 | 0.100 |
Why?
|
| Vascular Diseases | 1 | 1999 | 1182 | 0.090 |
Why?
|
| Pericardium | 1 | 2015 | 675 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 1 | 2009 | 7408 | 0.090 |
Why?
|
| Warfarin | 1 | 2018 | 1518 | 0.080 |
Why?
|
| Evidence-Based Medicine | 3 | 2010 | 3696 | 0.080 |
Why?
|
| Heart Conduction System | 1 | 2014 | 1015 | 0.080 |
Why?
|
| Sarcoidosis | 1 | 2014 | 520 | 0.080 |
Why?
|
| Veins | 1 | 2013 | 765 | 0.080 |
Why?
|
| Survival Rate | 2 | 2013 | 12808 | 0.080 |
Why?
|
| Intraoperative Complications | 1 | 2015 | 1186 | 0.080 |
Why?
|
| Middle Aged | 10 | 2018 | 220352 | 0.070 |
Why?
|
| Aged | 9 | 2020 | 169152 | 0.070 |
Why?
|
| Risk Factors | 6 | 2018 | 74359 | 0.070 |
Why?
|
| Advisory Committees | 1 | 2011 | 788 | 0.070 |
Why?
|
| Injections, Intravenous | 1 | 2009 | 1385 | 0.070 |
Why?
|
| Internationality | 1 | 2012 | 1004 | 0.070 |
Why?
|
| Canada | 1 | 2011 | 2128 | 0.060 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 58995 | 0.060 |
Why?
|
| Constriction | 1 | 2004 | 172 | 0.060 |
Why?
|
| Cardiomyopathies | 1 | 2014 | 1952 | 0.050 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 39261 | 0.050 |
Why?
|
| Heart Ventricles | 1 | 2014 | 3811 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2012 | 6360 | 0.050 |
Why?
|
| Time Factors | 3 | 2014 | 40165 | 0.050 |
Why?
|
| Hydrogen Peroxide | 1 | 2005 | 732 | 0.050 |
Why?
|
| Glutathione | 1 | 2004 | 582 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2014 | 8555 | 0.050 |
Why?
|
| Patient Selection | 2 | 2010 | 4283 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 6544 | 0.050 |
Why?
|
| Adult | 7 | 2018 | 219994 | 0.050 |
Why?
|
| Contractile Proteins | 1 | 2002 | 240 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2014 | 6218 | 0.050 |
Why?
|
| Young Adult | 3 | 2012 | 58741 | 0.050 |
Why?
|
| Pressure | 1 | 2004 | 1156 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2004 | 943 | 0.040 |
Why?
|
| Hypertrophy | 1 | 2002 | 555 | 0.040 |
Why?
|
| Environmental Exposure | 1 | 2015 | 4412 | 0.040 |
Why?
|
| Ventricular Fibrillation | 1 | 2022 | 539 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2012 | 41335 | 0.040 |
Why?
|
| Syndrome | 1 | 2005 | 3280 | 0.040 |
Why?
|
| Comorbidity | 1 | 2013 | 10551 | 0.040 |
Why?
|
| Electric Impedance | 1 | 2022 | 755 | 0.040 |
Why?
|
| Superoxides | 1 | 1999 | 387 | 0.040 |
Why?
|
| Decision Making | 1 | 2012 | 3925 | 0.040 |
Why?
|
| Stress, Mechanical | 1 | 2002 | 1666 | 0.030 |
Why?
|
| Vasoconstriction | 1 | 1999 | 593 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 2 | 2010 | 7475 | 0.030 |
Why?
|
| Aorta | 1 | 2004 | 2039 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 14495 | 0.030 |
Why?
|
| Vasodilation | 1 | 1999 | 962 | 0.030 |
Why?
|
| Arteriosclerosis | 1 | 1999 | 1064 | 0.030 |
Why?
|
| Incidence | 1 | 2013 | 21392 | 0.030 |
Why?
|
| Acute Disease | 1 | 2005 | 7269 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2002 | 1726 | 0.030 |
Why?
|
| Adolescent | 2 | 2012 | 87810 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2002 | 2141 | 0.030 |
Why?
|
| Retreatment | 1 | 2014 | 600 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1999 | 1485 | 0.030 |
Why?
|
| Hypercholesterolemia | 1 | 1999 | 1155 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2010 | 24123 | 0.020 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2014 | 504 | 0.020 |
Why?
|
| Antioxidants | 1 | 1999 | 1667 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2004 | 9530 | 0.020 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2014 | 784 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2005 | 18957 | 0.020 |
Why?
|
| Rats | 1 | 2005 | 23711 | 0.020 |
Why?
|
| Calcium | 1 | 2002 | 5725 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2004 | 12766 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 1999 | 4433 | 0.020 |
Why?
|
| Cytokines | 1 | 2002 | 7343 | 0.020 |
Why?
|
| Animals | 3 | 2005 | 167963 | 0.020 |
Why?
|
| Apoptosis | 1 | 2002 | 9501 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2015 | 2417 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2004 | 22023 | 0.020 |
Why?
|
| United States | 1 | 2013 | 72461 | 0.020 |
Why?
|
| Occupational Exposure | 1 | 2015 | 1809 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 6828 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2002 | 11903 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 8552 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2018 | 4897 | 0.010 |
Why?
|
| Recurrence | 1 | 2014 | 8482 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 1999 | 5889 | 0.010 |
Why?
|
| Hypertension | 1 | 1999 | 8594 | 0.010 |
Why?
|
| Mice | 1 | 2004 | 81208 | 0.010 |
Why?
|
| Algorithms | 1 | 2015 | 13981 | 0.010 |
Why?
|
Concepts
(144)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(11)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_